Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients
Key facts
- Who runs it
- Asian Institute of Gastroenterology, India
- Where
- India1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 158 people, planned
- Started
- 29 Nov 2023
- Planned end
- 30 Jul 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Per oral endoscopy myotomy
- Record updated
- 10 June 2025
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (5)Hide the full registry criteria
Who can take part
- Adult >18 years
- Diagnosis of Type 2 Achalasia cardia based on High resolution manometry
Who cannot take part
- Patients with previous endoscopic or surgical treatment for achalasia
- Patients with standard exclusion criteria for POEM procedure such as contraindication to general anesthesia, coagulopathy (international normalized ratio > 1.5, platelet count < 50 000/μL), portal hypertension, pregnancy, breast feeding women, and diffuse scarring in the esophagus due to previous surgery or radiation
- Patients with Type 1 \& 3 ACHALASIA CARDIA
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Esophageal diseases
This trial is currently available in India.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
- Consecutive eligible patients will be randomized in a 1:1 ratio to esophagogastric complex only myotomy or standard myotomy groups. Randomization is done according to the computer-generated algorithm. A clinical research coordinator will prepare the sealed randomization envelops and will hand over to the operating endoscopists before the beginning of the procedure. Written informed consent will be obtained from all participants. In this study, the participants and the care-provider assessing the clinical response to the POEM procedure at 3months will be blinded to the allocation.
The 2 groups in the trial
- Per oral endoscopy myotomy for standard myotomyExisting treatment, for comparison
Standard myotomy is muscle fibers cutting in esophagus more than 7 cms
Treatment: Per oral endoscopy myotomy
- Per oral endoscopy myotomy for esophago gastric junction myotomySham treatment, for comparison
Myotomy is muscle fibers cutting in esophagus less than 3 cms.
Treatment: Per oral endoscopy myotomy
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06870630, who can take part
- Record updated
- 10 June 2025